Publications

Vitamin D3 and Ischemic Stroke: A Narrative Review. Władysław Lasoń, Danuta Jantas, Monika Leśkiewicz, Magdalena Regulska, Agnieszka Basta-Kaim
Antioxidants (Basel, Switzerland), 2120 10.3390/antiox11112120
PMID:36358492
Thursday, 27 October 2022
Introduction to the Special Section on Katarzyna Głombik, Katarzyna Kuter-Nowak
Pharmacological reports : PR, 10.1007/s43440-022-00421-9
PMID:36149597
Friday, 23 September 2022
Comparison of an Addictive Potential of μ-Opioid Receptor Agonists with G Protein Bias: Behavioral and Molecular Modeling Studies. Lucja Kudla, Ryszard Bugno, Sabina Podlewska, Lukasz Szumiec, Lucja Wiktorowska, Andrzej J Bojarski, Ryszard Przewlocki
Pharmaceutics, 55 10.3390/pharmaceutics14010055
PMID:35056950
Monday, 27 December 2021
The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system. Katarzyna Z Kuter, Maria Śmiałowska, Krystyna Ossowska
Pharmacological reports : PR, 10.1007/s43440-021-00340-1
PMID:34762280
Thursday, 11 November 2021
The Impact of the Combined Administration of 1MeTIQ and MK-801 on Cell Viability, Oxidative Stress Markers, and Glutamate Release in the Rat Hippocampus. Agnieszka Wąsik, Magdalena Białoń, Danuta Jantas, Marcelina Żarnowska
Neurotoxicity research, 10.1007/s12640-021-00428-9
PMID:34665405
Tuesday, 19 October 2021
undefined Danuta Jantas, Janusz Malarz, Thanh Nguyen Le, Anna Stojakowska
International journal of molecular sciences, 10363 10.3390/ijms221910363
PMID:34638702
Sunday, 26 September 2021
Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications. Danuta Jantas, Władysław Lasoń
Antioxidants (Basel, Switzerland), 1518 10.3390/antiox10101518
PMID:34679652
Friday, 24 September 2021
Beyond the GFAP-Astrocyte Protein Markers in the Brain. Agnieszka M Jurga, Martyna Paleczna, Justyna Kadluczka, Katarzyna Z Kuter
Biomolecules, 1361 10.3390/biom11091361
PMID:34572572
Tuesday, 14 September 2021
Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease. Tomasz Lenda, Krystyna Ossowska, Klemencja Berghauzen-Maciejewska, Mikołaj Matłoka, Jerzy Pieczykolan, Maciej Wieczorek, Jolanta Konieczny
European journal of pharmacology, S0014-2999(21)00614-2 10.1016/j.ejphar.2021.174460
PMID:34469756
Sunday, 29 August 2021
Increased Beta-Hydroxybutyrate Level Is Not Sufficient for the Neuroprotective Effect of Long-Term Ketogenic Diet in an Animal Model of Early Parkinson's Disease. Exploration of Brain and Liver Energy Metabolism Markers. Katarzyna Z Kuter, Łukasz Olech, Urszula Głowacka, Martyna Paleczna
International journal of molecular sciences, 7556 10.3390/ijms22147556
PMID:34299176
Wednesday, 14 July 2021